ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
京玖康療-新
0.380
0.000
手動刷新
成交量:
- -
成交額:
- -
市值:
1.24億
市盈率:
- -
高:
0.380
開:
0.380
低:
0.380
收:
0.380
52周最高:
0.380
52周最低:
0.380
股本:
3.26億
香港流通股本:
3.26億
量比:
1.77
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
0.81
市盈率(LYR):
- -
市銷率:
- -
資料載入中...
總覽
公司
新聞
公告
京玖康療(00648):獨立非執行董事唐萃環獲委任為薪酬委員會、提名委員會及風險管理委員會成員
智通财经
·
08/19
BUZZ-英特爾股價盤前上漲,因軟銀投資介入
路透中文
·
08/19
BUZZ-英特爾股價盤前上漲,因軟銀投資介入
路透中文
·
08/19
京玖康療(00648)發佈中期業績 股東應占溢利335.3萬港元 同比扭虧為盈
智通财经
·
08/18
京玖康療擬8月18日舉行董事會會議以審批中期業績
和讯网
·
08/06
京玖康療繼續停牌 以待達成復牌條件
格隆汇资讯
·
07/31
京玖康療(00648)發佈年度業績,淨溢利3.26億港元,同比增長2508.24%
智通财经
·
03/25
京玖康療擬3月25日舉行董事會會議批准年度業績
格隆汇资讯
·
03/14
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/00648/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00648","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00648\",,,,,undefined,":{"symbol":"00648","market":"HK","secType":"STK","nameCN":"京玖康療-新","latestPrice":0.38,"timestamp":1756430409413,"preClose":0.38,"halted":3,"volume":0,"delay":0,"floatShares":326036828,"shares":326036828,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"08-29 09:20:09","open":0.38,"high":0.38,"low":0.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1756690200000},"marketStatusCode":7,"adr":0,"listingDate":657129600000,"exchange":"SEHK","adjPreClose":0.38,"openAndCloseTimeList":[[1756431000000,1756440000000],[1756443600000,1756454400000]],"volumeRatio":1.7730159632735405,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00648\",,,,,undefined,":{"symbol":"00648","floatShares":326036828,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.7730159632735405,"shares":326036828,"dividePrice":0,"high":0.38,"amplitude":0,"preClose":0.38,"low":0.38,"week52Low":0.38,"pbRate":"0.81","week52High":0.38,"institutionHeld":0,"latestPrice":0.38,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.38,"prevYearClose":0.44,"prevWeekClose":0.44,"prevMonthClose":0.44,"prevQuarterClose":0.44,"fiveDayClose":0.44,"twentyDayClose":0.44,"sixtyDayClose":0.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00648\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-25","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-30","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-27","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-05-19","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1684459800000,"name":null,"time":"","dateTimestamp":1684425600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00648\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00648\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00648\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560940051","title":"京玖康療(00648):獨立非執行董事唐萃環獲委任為薪酬委員會、提名委員會及風險管理委員會成員","url":"https://stock-news.laohu8.com/highlight/detail?id=2560940051","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560940051?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 21:21","pubTimestamp":1755609673,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)发布公告,独立非执行董事唐萃环女士已获委任为本公司薪酬委员会、提名委员会及风险管理委员会成员,自2025年8月19日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","BK1511"],"gpt_icon":0},{"id":"2560916692","title":"BUZZ-英特爾股價盤前上漲,因軟銀投資介入","url":"https://stock-news.laohu8.com/highlight/detail?id=2560916692","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560916692?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 16:08","pubTimestamp":1755590916,"startTime":"0","endTime":"0","summary":"8月19日 - ** 日本软银集团9984.T向英特尔INTC.O投资20亿美元后,英特尔INTC.O股价在盘前交易中大涨6%,至25美元。** 这项投资被视为对英特尔重振芯片制造业务、重新夺回技术领导地位的有力支持。** 软银股价在东京下跌近 5%;英特尔股价上涨,原因是投资者欢迎在扭亏为盈的努力中获得新的资金支持** 英特尔公司今年累计上涨约 18 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"355e71089ba825d3261393ee26c9e29f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nL4S3UB0H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4575","BK1511","BK4527","BK4534","BK4529","BK4141","BK4554","BK4602","INTC","BK4612","BK4579","BK4605","LU0081259029.USD","BK4512","BK4515","00648","LU2148611432.USD","LU0321505868.SGD","BK4535","BK4543","LU2543165471.USD","BK4588","BK4550","BK4533","LU0321505439.SGD"],"gpt_icon":1},{"id":"2560166928","title":"BUZZ-英特爾股價盤前上漲,因軟銀投資介入","url":"https://stock-news.laohu8.com/highlight/detail?id=2560166928","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560166928?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 16:08","pubTimestamp":1755590916,"startTime":"0","endTime":"0","summary":"8月19日 - ** 日本软银集团9984.T向英特尔INTC.O投资20亿美元后,英特尔INTC.O股价在盘前交易中大涨6%,至25美元。** 这项投资被视为对英特尔重振芯片制造业务、重新夺回技术领导地位的有力支持。** 软银股价在东京下跌近 5%;英特尔股价上涨,原因是投资者欢迎在扭亏为盈的努力中获得新的资金支持** 英特尔公司今年累计上涨约 18 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"355e71089ba825d3261393ee26c9e29f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nL4T3UB0H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4588","LU0321505439.SGD","BK4512","BK4529","LU0321505868.SGD","BK4605","LU2543165471.USD","BK4612","BK4515","INTC","BK4543","LU0081259029.USD","BK4585","BK4579","BK4602","BK4550","00648","BK4554","BK1511","BK4527","LU2148611432.USD","BK4141","BK4575","BK4535","BK4533"],"gpt_icon":1},{"id":"2560902926","title":"京玖康療(00648)發佈中期業績 股東應占溢利335.3萬港元 同比扭虧為盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2560902926","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560902926?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 19:59","pubTimestamp":1755518360,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)发布2025年中期业绩,收益3577.1万港元,同比增加16.5%;股东应占溢利335.3万港元,上年同期股东应占亏损609.3万港元,同比扭亏为盈;每股基本盈利1港仙。公告称,收益增长主要归因于集团持续努力扩充产品来源以扩阔产品组合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"京玖康疗(00648)发布中期业绩 股东应占溢利335.3万港元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","BK1511"],"gpt_icon":0},{"id":"2557837633","title":"京玖康療擬8月18日舉行董事會會議以審批中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2557837633","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557837633?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 18:47","pubTimestamp":1754477226,"startTime":"0","endTime":"0","summary":"格隆汇8月6日丨京玖康疗(00648.HK)公告,公司董事会宣布将于2025年8月18日(星期一)举行董事会会议,以批准刊发公司及其附属公司截至2025年6月30日未经审核中期业绩。公司股份将继续暂停买卖,以待达成复牌条件。公司股东及潜在投资者于买卖公司股份时务请审慎行事。本文来自和讯财经,更多精彩资讯请下载“和讯财经”APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080618521494d33c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080618521494d33c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1511","00648"],"gpt_icon":0},{"id":"2555882499","title":"京玖康療繼續停牌 以待達成復牌條件","url":"https://stock-news.laohu8.com/highlight/detail?id=2555882499","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555882499?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 18:46","pubTimestamp":1753958819,"startTime":"0","endTime":"0","summary":"格隆汇7月31日丨京玖康疗(00648.HK)公告,联交所于2020年4月21日知会公司将暂不行使上市规则第6.01A(2)(b)(i)条权利将公司除牌,惟视乎公司向证监会呈请进一步发展情况,可能在其认为适当的情况,于较后阶段行使上市规则第6.01A条权利。公司会继续解决证监会及联交所的关注。集团主要于香港从事分销医疗及健康设备及产品医疗及健康业务,其业务经营在所有重大方面均如常进行。董事会将继续监察停牌对集团经营及财务表现的影响,并采取适当应对措施。公司股份将继续暂停买卖,以待达成复牌条件。公司股东及潜在投资者于买卖本公司股份时务请审慎行事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507311847109729f0d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507311847109729f0d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00648","BK1511"],"gpt_icon":0},{"id":"2522075977","title":"京玖康療(00648)發佈年度業績,淨溢利3.26億港元,同比增長2508.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522075977","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522075977?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 20:50","pubTimestamp":1742907040,"startTime":"0","endTime":"0","summary":"智通财经APP讯,京玖康疗(00648)发布截至2024年12月31日止年度业绩,收益5463.9万港元,同比增长6.43%;年内溢利及全面收益总额3.26亿港元,同比增长2508.24%;每股盈利1港元。据悉,公司拥有人应占综合溢利3.26亿港元主要来自于年内以安排计划方式实施债务重组产生的一次性收益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","BK1511"],"gpt_icon":0},{"id":"2519893741","title":"京玖康療擬3月25日舉行董事會會議批准年度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2519893741","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519893741?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 06:47","pubTimestamp":1741906046,"startTime":"0","endTime":"0","summary":"格隆汇3月14日丨京玖康疗(00648.HK)宣布,董事会将于2025年3月25日(星期二)举行董事会会议,以批准刊发公司及其附属公司截至2024年12月31日的年度业绩。公司股份将继续暂停买卖,以待达成复牌条件。公司股东及潜在投资者于买卖公司股份时务请审慎行事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031406473998a6b64d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031406473998a6b64d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1511","00648"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}